Biktarvy, formally known as bictegravir sulfate, represents a effective single-tablet treatment for controlling HIV infection. This drug unites three key antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It works by preventing the the viral ability to copy within the body, remarkably lowering the viral quantity. For man